236 related articles for article (PubMed ID: 31585141)
21. Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome.
Guinea J; Torres-Narbona M; Gijón P; Muñoz P; Pozo F; Peláez T; de Miguel J; Bouza E
Clin Microbiol Infect; 2010 Jul; 16(7):870-7. PubMed ID: 19906275
[TBL] [Abstract][Full Text] [Related]
22. Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis.
Han SB; Kim SK; Lee JW; Yoon JS; Chung NG; Cho B; Jeong DC; Kang JH; Kim HK; Lee DG; Lee HS; Im SA
BMC Infect Dis; 2015 Jul; 15():271. PubMed ID: 26168914
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases: Comparison between Aspergillus fumigatus and non-fumigatus Aspergillus species.
Cho SY; Lee DG; Choi JK; Lee HJ; Kim SH; Park SH; Choi SM; Choi JH; Yoo JH; Park YJ; Lee JW
Medicine (Baltimore); 2017 Dec; 96(49):e8841. PubMed ID: 29245249
[TBL] [Abstract][Full Text] [Related]
24. Invasive pulmonary aspergillosis real-world outcomes: Clinical features and risk factors associated with increased mortality.
Henao-Martínez AF; Corbisiero MF; Salter I; Chastain DB; Thompson GR
Med Mycol; 2023 Aug; 61(8):. PubMed ID: 37491703
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
Lee DG; Lee HJ; Yan JL; Lin SS; Aram JA
Mycoses; 2019 Oct; 62(10):969-978. PubMed ID: 31355956
[TBL] [Abstract][Full Text] [Related]
26. Factors influencing mortality in neutropenic patients with haematologic malignancies or solid tumours with bloodstream infection.
Marín M; Gudiol C; Ardanuy C; Garcia-Vidal C; Jimenez L; Domingo-Domenech E; Pérez FJ; Carratalà J
Clin Microbiol Infect; 2015 Jun; 21(6):583-90. PubMed ID: 25680311
[TBL] [Abstract][Full Text] [Related]
27. Clinical Features and Prognosis of Invasive Pulmonary Aspergillosis in Korean Children with Hematologic/Oncologic Diseases.
Han SB; Kim SK; Bae EY; Lee JW; Yoon JS; Chung NG; Cho B; Jeong DC; Kang JH; Kim HK; Lee DG; Lee HS; Im SA
J Korean Med Sci; 2015 Aug; 30(8):1121-8. PubMed ID: 26240490
[TBL] [Abstract][Full Text] [Related]
28. Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007).
Lortholary O; Gangneux JP; Sitbon K; Lebeau B; de Monbrison F; Le Strat Y; Coignard B; Dromer F; Bretagne S;
Clin Microbiol Infect; 2011 Dec; 17(12):1882-9. PubMed ID: 21668573
[TBL] [Abstract][Full Text] [Related]
29. Clinical characteristics of 45 patients with invasive pulmonary aspergillosis: retrospective analysis of 1711 lung cancer cases.
Yan X; Li M; Jiang M; Zou LQ; Luo F; Jiang Y
Cancer; 2009 Nov; 115(21):5018-25. PubMed ID: 19637340
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
32. Subacute invasive pulmonary aspergillosis as a rare cause of pneumothorax in immunocompetent patient: brief report.
Vukicevic TA; Dudvarski-Ilic A; Zugic V; Stevanovic G; Rubino S; Barac A
Infection; 2017 Jun; 45(3):377-380. PubMed ID: 28233110
[TBL] [Abstract][Full Text] [Related]
33. Late Onset Invasive Pulmonary Aspergillosis in Lung Transplant Recipients in the Setting of a Targeted Prophylaxis/Preemptive Antifungal Therapy Strategy.
Herrera S; Davoudi S; Farooq A; Tikkanen J; Foroutan F; Kumar D; Humar A; Rotstein C; Singer LG; Keshavjee S; Husain S
Transplantation; 2020 Dec; 104(12):2575-2581. PubMed ID: 32080158
[TBL] [Abstract][Full Text] [Related]
34. Invasive pulmonary aspergillosis due to Aspergillus lentulus in an adult patient: A case report and literature review.
Yagi K; Ushikubo M; Maeshima A; Konishi M; Fujimoto K; Tsukamoto M; Araki K; Kamei K; Oyamada Y; Oshima H
J Infect Chemother; 2019 Jul; 25(7):547-551. PubMed ID: 30824299
[TBL] [Abstract][Full Text] [Related]
35. Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP-EBMT, EORTC-IDG and SEIFEM survey.
Lanternier F; Seidel D; Pagano L; Styczynski J; Mikulska M; Pulcini C; Maertens J; Munoz P; Garcia-Vidal C; Rijnders B; Arendrup MC; Sabino R; Verissimo C; Gaustad P; Klimko N; Arikan-Akdagli S; Arsic V; Barac A; Skiada A; Klingspor L; Herbrecht R; Donnelly P; Cornely OA; Lass-Flörl C; Lortholary O
Mycoses; 2020 May; 63(5):420-429. PubMed ID: 32009262
[TBL] [Abstract][Full Text] [Related]
36. New category of probable invasive pulmonary aspergillosis in haematological patients.
Girmenia C; Guerrisi P; Frustaci AM; Fama A; Finolezzi E; Perrone S; Gentile G; Collerone F; Brocchieri S; Guerrisi V
Clin Microbiol Infect; 2012 Oct; 18(10):990-6. PubMed ID: 21999366
[TBL] [Abstract][Full Text] [Related]
37. Combination antifungal therapy for invasive aspergillosis: a randomized trial.
Marr KA; Schlamm HT; Herbrecht R; Rottinghaus ST; Bow EJ; Cornely OA; Heinz WJ; Jagannatha S; Koh LP; Kontoyiannis DP; Lee DG; Nucci M; Pappas PG; Slavin MA; Queiroz-Telles F; Selleslag D; Walsh TJ; Wingard JR; Maertens JA
Ann Intern Med; 2015 Jan; 162(2):81-9. PubMed ID: 25599346
[TBL] [Abstract][Full Text] [Related]
38. Invasive Pulmonary Aspergillosis: Risks for Acquisition and Death in a Community Hospital.
Lane M; Szymeczek MA; Sherertz R; Meurtos K; Sciarretta JD; Davis JM
Surg Infect (Larchmt); 2018 Oct; 19(7):667-671. PubMed ID: 30227087
[TBL] [Abstract][Full Text] [Related]
39. Combination antifungal therapy for invasive mould diseases in haematologic patients. An update on clinical data.
Candoni A; Aversa F; Busca A; Cesaro S; Girmenia C; Luppi M; Rossi G; Venditti A; Nosari AM; Pagano L
J Chemother; 2015 Feb; 27(1):1-12. PubMed ID: 25466728
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of invasive aspergillosis and triazole-resistant Aspergillus fumigatus in patients with haematological malignancies: a single-centre retrospective cohort study.
Lestrade PP; van der Velden WJFM; Bouwman F; Stoop FJ; Blijlevens NMA; Melchers WJG; Verweij PE; Donnelly JP
J Antimicrob Chemother; 2018 May; 73(5):1389-1394. PubMed ID: 29394399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
